HIV serodiscordant relationships in India: translating science to practice.

PubWeight™: 0.88‹?›

🔗 View Article (PMC 3284098)

Published in Indian J Med Res on December 01, 2011

Authors

Sunil Suhas Solomon1, Suniti Solomon

Author Affiliations

1: Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Articles cited by this

Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36

Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med (2010) 50.17

Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med (2005) 42.71

Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet (2007) 38.98

Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet (2007) 37.69

Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science (2010) 35.19

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01

Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet (2001) 13.32

Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet (2010) 12.82

Pneumocystis pneumonia--Los Angeles. MMWR Morb Mortal Wkly Rep (1981) 7.82

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group. Lancet (1998) 7.53

HIV voluntary counseling and testing and behavioral risk reduction in developing countries: a meta-analysis, 1990--2005. AIDS Behav (2007) 4.61

Voluntary counseling and testing for couples: a high-leverage intervention for HIV/AIDS prevention in sub-Saharan Africa. Soc Sci Med (2001) 3.67

Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS (1998) 3.08

Effectiveness of needle-exchange programmes for prevention of HIV infection. Lancet (1997) 2.97

Marriage, monogamy and HIV: a profile of HIV-infected women in south India. Int J STD AIDS (2000) 2.59

Sexual practices, HIV and sexually transmitted infections among self-identified men who have sex with men in four high HIV prevalence states of India. AIDS (2008) 2.31

Evidence for HTLV-III infection in prostitutes in Tamil Nadu (India). Indian J Med Res (1987) 2.13

Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS (2000) 1.94

Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India. Clin Infect Dis (2007) 1.83

HIV in India--a complex epidemic. N Engl J Med (2007) 1.62

Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr (2005) 1.61

The social dynamics of HIV transmission as reflected through discordant couples in rural Uganda. AIDS (1995) 1.55

The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse (2010) 1.18

Social-structural contexts of needle and syringe sharing behaviours of HIV-positive injecting drug users in Manipur, India: a mixed methods investigation. Harm Reduct J (2011) 1.09

Descriptive epidemiology of intravenous heroin users--a new risk group for transmission of HIV in India. J Infect (1991) 1.02

A rapid situation and response assessment of the female regular sex partners of male drug users in South Asia: factors associated with condom use during the last sexual intercourse. Int J Drug Policy (2008) 0.99

The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health (2011) 0.92

Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. Am J Epidemiol (2010) 0.89

Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals. J Acquir Immune Defic Syndr (2006) 0.84

Needle sharing and other behaviours related to HIV spread among intravenous drug users. AIDS (1989) 0.83

Articles by these authors

(truncated to the top 100)

Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. N Engl J Med (2008) 6.00

Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study. AIDS Patient Care STDS (2005) 2.92

High HIV prevalence and risk behaviors in men who have sex with men in Chennai, India. J Acquir Immune Defic Syndr (2004) 2.66

Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis (2002) 2.39

Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr (2006) 2.30

High frequency of clinically significant mutations after first-line generic highly active antiretroviral therapy failure: implications for second-line options in resource-limited settings. Clin Infect Dis (2009) 2.17

When HIV-prevention messages and gender norms clash: the impact of domestic violence on women's HIV risk in slums of Chennai, India. AIDS Behav (2003) 2.12

Intimate partner violence is as important as client violence in increasing street-based female sex workers' vulnerability to HIV in India. Int J Drug Policy (2008) 1.97

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr (2004) 1.97

Comorbidities among HIV-infected injection drug users in Chennai, India. Indian J Med Res (2008) 1.95

The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis (2005) 1.95

High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr (2008) 1.81

Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr (2002) 1.71

Safety, tolerability and effectiveness of generic HAART in HIV-infected children in South India. J Trop Pediatr (2008) 1.63

Factors associated with injection cessation, relapse and initiation in a community-based cohort of injection drug users in Chennai, India. Addiction (2011) 1.62

Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr (2005) 1.61

High HIV burden among people who inject drugs in 15 Indian cities. AIDS (2015) 1.60

A survey of MSM HIV prevention outreach workers in Chennai, India. AIDS Educ Prev (2006) 1.58

HIV/AIDS stigma: reliability and validity of a new measurement instrument in Chennai, India. AIDS Behav (2007) 1.47

GB virus infection: a silent anti-HIV panacea within? Trans R Soc Trop Med Hyg (2008) 1.44

The emerging HIV epidemic among men who have sex with men in Tamil Nadu, India: geographic diffusion and bisexual concurrency. AIDS Behav (2010) 1.43

Clinical profile of HIV in India. Indian J Med Res (2005) 1.41

A Phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C-modified vaccinia Ankara virus vaccine candidate in Indian volunteers. AIDS Res Hum Retroviruses (2009) 1.35

Acceptability of a microenterprise intervention among female sex workers in Chennai, India. AIDS Behav (2010) 1.34

HIV type 1 genotypic variation in an antiretroviral treatment-naive population in southern India. AIDS Res Hum Retroviruses (2005) 1.31

Sexual behaviors of individuals with HIV living in South India: a qualitative study. AIDS Educ Prev (2007) 1.31

Associations between social capital and HIV stigma in Chennai, India: considerations for prevention intervention design. AIDS Educ Prev (2009) 1.31

Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus. J Int Neuropsychol Soc (2006) 1.30

Dried blood spots (DBS): a valuable tool for HIV surveillance in developing/tropical countries. Int J STD AIDS (2002) 1.29

The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS (2003) 1.27

High proportion of isosporiasis among HIV-infected patients with diarrhea in southern India. Am J Trop Med Hyg (2007) 1.26

Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS (2008) 1.26

The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug Alcohol Depend (2010) 1.23

Sexual health promotion in Chennai, India: key role of communication among social networks. Health Promot Int (2005) 1.22

Development of an opinion leader-led HIV prevention intervention among alcohol users in Chennai, India. AIDS Educ Prev (2004) 1.20

The profile of injection drug users in Chennai, India: identification of risk behaviours and implications for interventions. Subst Use Misuse (2010) 1.18

HIV-related stigma, isolation, discrimination, and serostatus disclosure: a global survey of 2035 HIV-infected adults. J Int Assoc Physicians AIDS Care (Chic) (2012) 1.18

Predictors of nonadherence to highly active antiretroviral therapy among HIV-infected South Indians in clinical care: implications for developing adherence interventions in resource-limited settings. AIDS Patient Care STDS (2010) 1.17

Multiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance. J Biol Chem (2012) 1.16

Microbicides--aids to safer sex. Lancet (2004) 1.14

Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr (2004) 1.13

Low-cost monitoring of HIV infected individuals on highly active antiretroviral therapy (HAART) in developing countries. Indian J Med Res (2005) 1.12

Exploring "wine shops" as a venue for HIV prevention interventions in urban India. J Urban Health (2007) 1.12

Greater severity and extent of periodontal breakdown in 136 south Indian human immunodeficiency virus seropositive patients than in normal controls: a comparative study using community periodontal index of treatment needs. Indian J Dent Res (2007) 1.10

Mortality among injection drug users in Chennai, India (2005-2008). AIDS (2009) 1.09

An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries. J Acquir Immune Defic Syndr (2004) 1.09

HIV rates and risk behaviors are low in the general population of men in Southern India but high in alcohol venues: results from 2 probability surveys. J Acquir Immune Defic Syndr (2007) 1.09

Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis (2010) 1.09

Adherence to antiretroviral therapy in patients participating in a graduated cost recovery program at an HIV care center in South India. AIDS Behav (2010) 1.07

Viremia and HIV-1 drug resistance mutations among patients receiving second-line highly active antiretroviral therapy in Chennai, Southern India. Clin Infect Dis (2012) 1.07

Hepatitis B virus and hepatitis C virus dual infection among patients with chronic liver disease. J Microbiol Immunol Infect (2009) 1.07

Perceptions about the acceptability of assessments of HIV medication adherence in Lilongwe, Malawi and Chennai, India. AIDS Behav (2006) 1.05

Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India. Int J Infect Dis (2009) 1.04

High prevalence of forced sex among non-brothel based, wine shop centered sex workers in Chennai, India. AIDS Behav (2011) 1.04

Oral lesions among persons with HIV disease with and without highly active antiretroviral therapy in southern India. J Oral Pathol Med (2007) 1.03

Value of single acid-fast bacilli sputum smears in the diagnosis of tuberculosis in HIV-positive subjects. J Med Microbiol (2007) 1.02

Low-cost assays for monitoring HIV infected individuals in resource-limited settings. Indian J Med Res (2011) 1.02

Clinical manifestations of HIV infected children. Indian J Pediatr (2003) 1.01

Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India. Clin Infect Dis (2006) 1.01

High HIV prevalence and incidence among MSM across 12 cities in India. AIDS (2015) 0.99

Association of hepatitis C virus infection with sexual exposure in southern India. Clin Infect Dis (2003) 0.99

Dried blood spots versus plasma for the quantitation of HIV-1 RNA using a real-Time PCR, m2000rt assay. J Virol Methods (2012) 0.99

An evaluation of methods to improve the reporting of adherence in a placebo gel trial in Andhra Pradesh, India. AIDS Behav (2013) 0.97

A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings. J Acquir Immune Defic Syndr (2006) 0.97

Urinary infections due to multi-drug-resistant Escherichia coli among persons with HIV disease at a tertiary AIDS care centre in South India. Nephron Clin Pract (2008) 0.97

The association of health-care use and hepatitis C virus infection in a random sample of urban slum community residents in southern India. Am J Trop Med Hyg (2003) 0.96

Living with HIV infection: perceptions of patients with access to care at a non-governmental organization in Chennai, India. Cult Health Sex (2006) 0.96

Epidemiology of hepatitis C virus infection & liver disease among injection drug users (IDUs) in Chennai, India. Indian J Med Res (2010) 0.96

Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients. AIDS (2005) 0.95

A descriptive profile of abused female sex workers in India. J Health Popul Nutr (2010) 0.94

Use of an HIV-1 reverse-transcriptase enzyme-activity assay to measure HIV-1 viral load as a potential alternative to nucleic acid-based assay for monitoring antiretroviral therapy in resource-limited settings. J Med Microbiol (2007) 0.92

Measuring perceived stigma in female sex workers in Chennai, India. AIDS Care (2011) 0.92

The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health (2011) 0.92

HIV treatment adherence, patient health literacy, and health care provider-patient communication: results from the 2010 AIDS Treatment for Life International Survey. J Int Assoc Physicians AIDS Care (Chic) (2012) 0.91

Preparing for efficacy trials of vaginal microbicides in Indian women. Indian J Med Res (2005) 0.90

The relationship between social network factors, HIV, and Hepatitis C among injection drug users in Chennai, India. Drug Alcohol Depend (2011) 0.90

Establishment of T-lymphocyte subset reference intervals in a healthy adult population in Chennai, India. Indian J Med Res (2009) 0.89

Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. Am J Epidemiol (2010) 0.89

Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.89

A social cognitive model of health for HIV-positive adults receiving care in India. AIDS Behav (2007) 0.88

Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 0.87

Evaluation and diagnostic usefulness of domestic and imported enzyme-linked immunosorbent assays for detection of human immunodeficiency virus type 1 antibody in India. Clin Diagn Lab Immunol (2005) 0.87

Orofacial and systemic manifestations in 212 paediatric HIV patients from Chennai, South India. Int J Paediatr Dent (2010) 0.87

Behavioural and medical predictors of bacterial vaginosis recurrence among female sex workers: longitudinal analysis from a randomized controlled trial. BMC Infect Dis (2013) 0.86

Does CD4+CD25+foxp3+ cell (Treg) and IL-10 profile determine susceptibility to immune reconstitution inflammatory syndrome (IRIS) in HIV disease? J Inflamm (Lond) (2008) 0.86

Intermediate vaginal flora is associated with HIV prevalence as strongly as bacterial vaginosis in a cross-sectional study of participants screened for a randomised controlled trial. Sex Transm Infect (2012) 0.85

Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients. J Int Assoc Physicians AIDS Care (Chic) (2011) 0.85

Immune reconstitution inflammatory syndrome in association with HIV/AIDS and tuberculosis: views over hidden possibilities. AIDS Res Ther (2007) 0.85

Sexually transmitted infections and reproductive health morbidity in a cohort of female sex workers screened for a microbicide feasibility study in Nellore, India. Glob J Health Sci (2013) 0.85

Risk reduction counseling is associated with decreased HIV transmission-associated behaviors in high-risk Indian heterosexuals. J Acquir Immune Defic Syndr (2006) 0.84

The prevalence of hepatitis B virus and hepatitis C virus infection among patients with chronic liver disease in South India. Int J Infect Dis (2008) 0.84

Sexual risk behaviors among HIV-infected South Indian couples in the HAART era: implications for reproductive health and HIV care delivery. AIDS Care (2011) 0.84

Wet mounting using iodine-glycerol provides a semi-permanent preparation for microscopic observation of faecal parasites. J Med Microbiol (2008) 0.84

Cold agglutinins in HIV-seropositive participants and diagnosis of respiratory disease due to Mycoplasma pneumoniae. J Int Assoc Physicians AIDS Care (Chic) (2009) 0.84

TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens. J Acquir Immune Defic Syndr (2013) 0.83

Safe substitution to zidovudine among HIV-infected patients initiated on stavudine-containing highly active antiretroviral therapy from a resource-limited setting. Int J Infect Dis (2009) 0.83

Bacterial vaginosis in women of low socioeconomic status living in slum areas in Chennai, India. Sex Health (2006) 0.82

Challenges of expansion of voluntary counselling and testing in India. Sex Health (2008) 0.82

Using a 2-stage strategy with respondent-driven sampling to recruit a hard-to-reach population for a placebo microbicide gel clinical trial in Nellore, Andhra Pradesh (India). AIDS Behav (2015) 0.82

Serosurveillance of acute Mycoplasma pneumoniae infection among HIV infected patients with pulmonary complaints in Chennai, Southern India. J Infect (2006) 0.81